Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 10:32 AM
Ignite Modification Date:
2025-12-26 @ 10:32 AM
NCT ID:
NCT00001128
Eligibility Criteria:
Inclusion Criteria
Patients may be eligible for this study if they:
* Are HIV-positive.
* Have a CD4 cell count below 150 cells/mm3.
* Have been on stable anti-HIV therapy that includes at least 2 nucleoside analogues for at least 4 weeks.
* Have chronic diarrhea (3 bowel movements a day that are loose or watery, for 5 days per week over 3 weeks).
* Test positively for Cryptosporidium.
* Are at least 18 years old.
* Agree to use effective methods of birth control.
Exclusion Criteria
Patients will not be eligible for this study if they:
* Have any other active opportunistic (AIDS-related) infection.
* Require intravenous (IV) fluids.
* Have a history of an allergy to certain medications, such as colony-stimulating factors (G-CSF or GM-CSF) or a type of antibiotic.
* Are pregnant.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00001128
Study Brief:
Protocol Section:
NCT00001128